ReviewBMJ global health2017
Assessing the population at risk of Zika virus in Asia - is the emergency really over?
Review in BMJ global health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Does prior dengue virus exposure worsen clinical outcomes of Zika virus infection? A systematic review, pooled analysis and lessons learned.PLoS neglected tropical diseases · 2019Pooled it
- Antibody Immunity to Zika Virus among Young Children in a Flavivirus-Endemic Area in Nicaragua.Viruses · 2023Article
- Scoping future outbreaks: a scoping review on the outbreak prediction of the WHO Blueprint list of priority diseases.BMJ global health · 2021Article
- Warming temperatures could expose more than 1.3 billion new people to Zika virus risk by 2050.Global change biology · 2021Article
- Mapping the cryptic spread of the 2015-2016 global Zika virus epidemic.BMC medicine · 2020Article
- Genomic Epidemiology as a Public Health Tool to Combat Mosquito-Borne Virus Outbreaks.The Journal of infectious diseases · 2020Review
- Serologic surveillance of maternal Zika infection in a prospective cohort in Leon, Nicaragua during the peak of the Zika epidemic.PloS one · 2020Article
- Low seroprevalence rates of Zika virus in Kuala Lumpur, Malaysia.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2019Article
- Temperature impacts on dengue emergence in the United States: Investigating the role of seasonality and climate change.Epidemics · 2019Article
- Knowledge and attitude towards pregnancy-related issues of Zika virus infection among general practitioners in Indonesia.BMC infectious diseases · 2019Article
- Downgrading disease transmission risk estimates using terminal importations.PLoS neglected tropical diseases · 2019Article
- Serologic Tools and Strategies to Support Intervention Trials to Combat Zika Virus Infection and Disease.Tropical medicine and infectious disease · 2019Review
- Zika Outbreak Emergency Preparedness and Response of Malaysian Private Healthcare Professionals: Are They Ready?Microorganisms · 2019Article
- Global expansion and redistribution of Aedes-borne virus transmission risk with climate change.PLoS neglected tropical diseases · 2019Article
- The Asian Lineage of Zika Virus: Transmission and Evolution in Asia and the Americas.Virologica Sinica · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
On November 18, 2016, the WHO ended its designation of the Zika virus (ZIKV) epidemic as a Public Health Emergency of International Concern (PHEIC). At the same time, ZIKV transmission continues in Asia, with the number of Asian countries reporting Zika cases increasing over the last 2 years. Applying a method that combines epidemiological theory with data on epidemic size and drivers of transmission, we characterised the population at risk of ZIKV infection from
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.